Cheng-Tai Lu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Cheng-Tai Lu

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Bioorganic & Medicinal Chemistry|March 6, 2009

Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitorsTing-Yueh Tsai, Tsu Hsu, Chiung-Tong Chen, et al.

Journal of Medicinal Chemistry|April 11, 2019

Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT MutantsTsung-Sheng Wu, Wen-Hsing Lin, Hui-Jen Tsai, et al.

Journal of Medicinal Chemistry|November 14, 2019

Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid LeukemiaWen-Hsing Lin, Su-Ying Wu, Teng-Kuang Yeh, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Bioorganic & Medicinal Chemistry|March 6, 2009

Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitorsTing-Yueh Tsai, Tsu Hsu, Chiung-Tong Chen, et al.

Journal of Medicinal Chemistry|April 11, 2019

Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT MutantsTsung-Sheng Wu, Wen-Hsing Lin, Hui-Jen Tsai, et al.

Journal of Medicinal Chemistry|November 14, 2019

Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid LeukemiaWen-Hsing Lin, Su-Ying Wu, Teng-Kuang Yeh, et al.

Pageof 2